-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
-
Summary
-
Travere Therapeutics, Inc. quarterly/annual Income Tax Expense (Benefit) history and growth rate from 2013 to 2023.
- Travere Therapeutics, Inc. Income Tax Expense (Benefit) for the quarter ending September 30, 2024 was -$84K, a 800% decline year-over-year.
- Travere Therapeutics, Inc. Income Tax Expense (Benefit) for the twelve months ending September 30, 2024 was $260K, a 19.3% increase year-over-year.
- Travere Therapeutics, Inc. annual Income Tax Expense (Benefit) for 2023 was $223K, a 28.8% decline from 2022.
- Travere Therapeutics, Inc. annual Income Tax Expense (Benefit) for 2022 was $313K, a 23.5% decline from 2021.
- Travere Therapeutics, Inc. annual Income Tax Expense (Benefit) for 2021 was $409K.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Annual (USD)
Income Tax Expense (Benefit), YoY Annual Growth (%)